AP NEWS
ADVERTISEMENT
Press release content from Accesswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Accesswire
Press release content from Accesswire. The AP news staff was not involved in its creation.

CardioComm HeartCheck(TM) Wireless, Wearable 12 Lead ECG and Holter Patch Solution for Remote and in Home ECG Monitoring Planned for 2021

December 23, 2020 GMT

Patient Self-Monitoring with ECG Triaging Services will Support Remote Monitoring Needs

TORONTO, ON / ACCESSWIRE / December 23, 2020 / CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm” or the “Company”), a global provider of consumer heart monitoring and electrocardiogram (“ECG”) device and software solutions, confirms plans to develop a multi-lead, wireless, ECG patch device for use in clinics, skilled nursing facilities, clinical trials as well as to support remote patient monitoring (“RPM”) and telehealth services and prescribed in-home arrhythmia monitoring.

The wearable innovation is a result of a software/hardware partnership agreement with South Korea based Healthrian Co. Ltd. (“Healthrian”). The HeartCheck™ 12 lead/Holter/event ECG platform will include a compact, rechargeable and water proof ECG recorder, a self-placed disposable ECG patch with pre-alignment anatomical placement of electrodes, a smartphone mobile app and a HIPAA-compliant cloud-based ECG management solution that will support automated algorithm assisted, and manual reviews and reporting, of uploaded ECG recordings.

ADVERTISEMENT

CardioComm has already implemented a family of ECG management systems that can support one to 12 leads of ECG data of varying durations that are licensed under the Global ECG Management Solution (“GEMS™” ) and GlobalCardio™ product brands with Health Canada and the Food and Drug Administration (“FDA”) Class II medical device clearances for the sale of over-the-counter and through prescription. Healthrian has developed a novel 12 lead ECG monitoring hardware solution using an ECG module that can connect via Bluetooth to a Smart device for the transfer of collected multi-channel ECG data. The module can use a number of different ECG electrode options including a patch or conventional ECG cables. Healthrian and CardioComm plan to integrate their respective technologies to bring multiple new medical and wellness devices to service the ambulatory ECG and arrhythmia monitoring markets globally.

CardioComm will be the lead applicant for medical device clearances with the FDA and Health Canada and will leverage their cleared GEMS™ and GlobalCardio™ software technologies, existing Medical Device Establishment Licenses and the Company’s ISO 13485:2016 MDSAP quality management system certification for both countries to streamline the application process.

Two phases of medical device applications are planned. The first phase will be eminent and will accommodate the wearable, wireless, ECG monitor in a standard configuration to record 12 lead ECGs for durations of a few seconds (resting) to a few days (ambulatory) using conventional lead sets with traditional disposable single ECG electrodes or alternatively using a disposable, multi-lead (12) ECG patch. The first phase will include integration with CardioComm’s existing medical device cleared software. The companies will continue development of their technologies with plans to release a configurable device with selectable inputs of one to 12 leads of data as a resting ECG monitor or as a Holter/event monitor for continuous and long term ECG monitoring (up to 30 days). The second phase will be associated with new CardioComm software medical device clearances for Holter with automated arrhythmia detection and classification technologies.

ADVERTISEMENT

The Company confirms that software/device integration and compatibility testing has been completed. To learn more about CardioComm’s products and for further product updates please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485:2016 MDSAP certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer

1-877-977-9425 x227

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: CardioComm Solutions, Inc

View source version on accesswire.com:

https://www.accesswire.com/622187/CardioComm-HeartCheckTM-Wireless-Wearable-12-Lead-ECG-and-Holter-Patch-Solution-for-Remote-and-in-Home-ECG-Monitoring-Planned-for-2021